Clinical trial
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
NCT00432744 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00432744 |
|---|---|
| Title | Phase III Trial of Coenzyme Q10 in Mitochondrial Disease |
| Official title | Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease |
| Lead sponsor | University of Florida, Other |
| Collaborators | FDA Office of Orphan Products Development U.S. Fed Food and Drug Administration (FDA) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mitochondrial Diseases |
| Intervention type | Drug |
| Interventions | CoenzymeQ10, Placebo |
| Enrollment | 24 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Feb 8, 2007 |
| Last update posted | Sep 11, 2017 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: